Fluidigm can connect you with COVID-19 testing services. Visit fluidigm.com/community-connect to learn more.

Development, validation & implementation of custom genotyping panels using microfluidics technology

Jessica McDevitt, MS
Associate Director, Development Projects
Infinity BiologiX

For Research Use Only. Not for use in diagnostic procedures.

Information in this publication is subject to change without notice. Patent and license information: fluidigm.com/legal/notices. Trademarks: Fluidigm, the Fluidigm logo, Access Array, Biomark, Delta Gene, Dynamic Array, EPI, Juno and SNP Type are trademarks and/or registered trademarks of Fluidigm Corporation in the United States and/or other countries. All other trademarks are the sole property of their respective owners. © 2021 Fluidigm Corporation. All rights reserved. 06/2021

A leader in state-of-the-art molecular testing technology, Infinity BiologiX LLC (IBX) uses microfluidics to perform more than 200,000 genotyping reactions a day. IBX uses the Fluidigm Dynamic Array™ integrated fluidic circuit (IFC) for daily functional quality control and a variety of custom genomic panels. Dynamic Array offers an alternative to plate-based genotyping and gene expression methods. One 96.96 Dynamic Array can perform 9,216 individual reactions in just under 4 hours, the equivalent of running 24 individual 384-well plates. With nanoliter reactions, expensive reagents are conserved, data is delivered quickly, and hands-on time is reduced. High-quality data from microfluidics-based methods is consistent, and panels are highly customizable. Using multiple configurations, IBX can meet a variety of research needs with speed and accuracy. IBX has developed a variety of custom panels using Fluidigm’s microfluidics technology, providing new methods to optimize throughput and provide high-quality data to clients.

Embed